MTHFR C677T and A1298C: How to Read Your Genotype Results

If you have been told to "look into MTHFR," or you have run across the term in a lab report or an online forum, the vocabulary can be intimidating. C677T. A1298C. Heterozygous. Compound heterozygous. None of these words is a diagnosis. They are descriptions of small, common differences in a single gene, and what they tell you is fairly narrow: how efficiently one particular enzyme in your body is likely to work. This article explains what the MTHFR gene does, what the two common variants mean, how to read a genotype result, and, just as importantly, what a result cannot tell you. It is educational information rather than medical advice, and any result is best reviewed with your healthcare provider.

What the MTHFR Gene Actually Does

MTHFR is short for methylenetetrahydrofolate reductase, which is the name of an enzyme. The MTHFR gene carries the instructions your cells use to build that enzyme. The enzyme has one main job in the folate pathway: it converts 5,10-methylenetetrahydrofolate into 5-methyltetrahydrofolate, better known as L-methylfolate. That is the circulating form of folate the body uses in the methylation cycle, a set of biochemical reactions involved in building DNA, producing neurotransmitters, and recycling the amino acid homocysteine back into methionine.

Folate from leafy greens, and folic acid from fortified grains and most standard supplements, are not usable in that form. They pass through several enzymatic steps first, and MTHFR catalyzes the last one. Common variations in the gene sequence can change the shape of the enzyme slightly and reduce how efficiently it performs that conversion. That is the whole story a genotype tells: the likely efficiency of one conversion step. It is recognized biochemistry, and much less dramatic than the internet makes it sound.

C677T and A1298C in Plain Language

The names look like code because they are. Each describes a single-letter change at a specific position in the gene sequence, what geneticists call a single nucleotide polymorphism. In C677T, the letter C is replaced by a T at position 677. In A1298C, an A is replaced by a C at position 1298. These are the two variants that consumer MTHFR testing reports, because they are the two most studied in relation to folate metabolism.

Both are common in the general population. A variant that a large share of people carry is a normal piece of human variation, not a defect. Research has investigated C677T more extensively, and laboratory measurements have associated it with a greater reduction in enzyme activity, particularly in people who carry two copies. A1298C has generally been associated with a smaller effect on measured enzyme activity. Neither variant is, in itself, a disease.

Heterozygous, Homozygous, and Compound Heterozygous

You inherit two copies of most genes, one from each biological parent, so a result reports on both copies.

No variant detected: Both copies carry the common sequence at that position, and enzyme activity is considered typical.

Heterozygous: One copy carries the variant and the other does not. A heterozygous MTHFR gene result is common, and it is generally associated with a modest reduction in enzyme efficiency.

Homozygous: Both copies carry the same variant, for example C677T on both. Laboratory studies have associated the homozygous C677T genotype with the largest reduction in measured enzyme activity among the common genotypes.

Compound heterozygous: One copy carries C677T and the other carries A1298C. Because both variants are present, this combination is usually reported as its own genotype and has been studied as such.

These words describe a pattern of inheritance, not a severity of illness. Two people with an identical genotype can have very different diets, B-vitamin status, medications, and overall health. Genotype is one input among many, and it does not tell you how your metabolism is running today.

What an MTHFR Result Does Not Tell You

This is the part most worth reading twice. Professional genetics organizations have generally taken the position that MTHFR genotyping is not warranted as a routine population screen, in part because these variants are common and carrying one does not establish that a person has, or will develop, any disease. A result is a piece of metabolic information. It is not a verdict.

It is not a diagnosis: A genotype describes a sequence of DNA, not a condition. Carrying a variant does not mean something is wrong with you.

It is not a prediction: A result cannot tell you what will happen to your health.

It does not measure your nutrient status: Folate, vitamin B12, and homocysteine levels are measured with blood tests your provider orders. A genotype cannot substitute for them.

It does not explain your symptoms by itself: Symptoms have many possible causes, and only a clinician who knows your full history can work through them with you.

How the At-Home MTHFR Test Kit Works

The MTHFR Test Kit offered through Iaomai is a simple at-home genetic test that identifies whether you carry the C677T and A1298C variants that affect folate metabolism. There is no lab visit and no appointment to schedule.

Order the kit online: The kit is shipped to you, so the process starts and ends at home.

Collect a saliva sample: You follow the instructions included in the kit. There is no blood draw.

Mail it back: A prepaid return envelope is included, so there is nothing to arrange or pay for when you send the sample to the lab.

Review your results securely: Results are delivered through a secure online portal, typically within one to two weeks.

On the question of MTHFR testing cost, which comes up often because genetic-testing pricing is opaque: the current price is listed on the test kit page, and the kit does not require insurance. Some patients may be able to submit the cost for HSA or FSA reimbursement, which is worth checking with your plan administrator.

Reviewing Your Results With Your Provider

Take the result to your healthcare provider. They can read it alongside your history, your medications, your diet, and any bloodwork they think is relevant. They are the right person to tell you whether the result means anything for you, and often the honest answer is that it changes very little.

Where a result can be genuinely useful is in the conversation about the form of folate in what you take. Folic acid, the synthetic form found in fortified foods and many standard supplements, depends on that final MTHFR-catalyzed conversion step before the body can use it. L-methylfolate is already in the active form the methylation cycle uses, so it does not depend on that step. If your result suggests reduced MTHFR enzyme efficiency, the difference between those two forms is one of the factors your provider may weigh.

Several Iaomai medical foods, including EB-C3, EB-N5, and EB-MATRIX, are formulated with L-methylfolate and methylcobalamin, the bioactive forms of folate and vitamin B12. Medical foods are a distinct regulatory category: they are formulated for the dietary management of a condition with distinctive nutritional requirements, and they are intended for use under the supervision of a physician. They are not drugs and they are not dietary supplements. A genotype result on its own does not establish that any product is appropriate for you, and nothing here should be read as a promise of a health outcome. Whether a methylated-folate formulation suits you is a decision to make under the supervision of your healthcare provider.

A genotype is a small, specific piece of information. Knowing it can make the conversation with your provider more precise. It cannot, on its own, tell you that you are sick or that you are well.